Sophie Goyard

Sophie Goyard

Auto-generated profile, based on publicly available information

Sophie Goyard

Unité de Biochimie des Régulations Cellulaires, Institut Pasteur, Paris, France

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2003 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
SGSophie Goyard
Sophie Goyard
HSHiroaki Segawa
Hiroaki Segawa
JGJennifer Gordon
Jennifer Gordon
MSMelissa Showalter
Melissa Showalter
RDRobert Duncan
Robert Duncan
SBStephen Beverley
Stephen Beverley

6 April 2011 in Molecular Microbiology
Verified
Journal Article
Closed access
PDF file
JBJulie Bonhomme
Julie Bonhomme
MCMurielle Chauvel
Murielle Chauvel
SGSophie Goyard
Sophie Goyard
PRPascal Roux
Pascal Roux
TRTristan Rossignol
Tristan Rossignol
CDChristophe D'Enfert
Christophe D'Enfert

1 May 2005 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
EBEfrat Barak
Efrat Barak
SASigal Amin-Spector
Sigal Amin-Spector
EGElena Gerliak
Elena Gerliak
SGSophie Goyard
Sophie Goyard
NHNeta Holland
Neta Holland
DZDan Zilberstein
Dan Zilberstein

1 November 2004 in Cellular Microbiology
Verified
Journal Article
Open access
PDF file
TLThierry Lang
Thierry Lang
SGSophie Goyard
Sophie Goyard
MLMai Lebastard
Mai Lebastard
GMGenevieve Milon
Genevieve Milon
In this study, we have established conditions for generating Leishmania amazonensis recombinants stably expressing the firefly luciferase gene. These parasites produced significant bioluminescent signals for both in vitro studies and the development of an in vivo model, allowing the course of the parasitism to be readily monitored in real time in the living animals such as laboratory mice. First, a model was established, using parasite-infected mouse macrophages for rapidly determining the activity of drugs against intracellular amastigotes. Results indicated that recombinant Leishmania can be reliably and confidently used to monitor compounds acting on intracel-lular amastigote-harbouring macrophages. Secondly, temporal analyses were performed following inoculation of metacyclic promastigotes into the ear dermis of BALB/c mice and the bioluminescent light transmitted through the tissue was imaged externally using a charge coupled device (CCD) camera. Bioluminescent signals, measured at the inoculation site and in the draining lymph node of mice containing these parasites correlated well with the more classical quantification of parasites. These assays prove that the real-time bioluminescent assay is not only sensitive but also more rapid than culture-base techniques allowing to monitor parasite-load before any clinical signs of leishmaniasis are detectable. In short, this luciferase imaging study is useful to monitor the efficacy of anti-leishmanial drugs on live cell culture and to trace leishmanial infection in animal models.

25 September 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MCMurielle Chauvel
Murielle Chauvel
ANAudrey Nesseir
Audrey Nesseir
Vitor CabralVitor Cabral
Vitor Cabral
Sadri ZNAIDISadri ZNAIDI
Sadri ZNAIDI
SGSophie Goyard
Sophie Goyard
CDChristophe D'Enfert
Christophe D'Enfert
Candida albicans is the most frequently encountered human fungal pathogen, causing both superficial infections and life-threatening systemic diseases. Functional genomic studies performed in this organism have mainly used knock-out mutants and extensive collections of overexpression mutants are still lacking. Here, we report the development of a first generation C. albicans ORFeome, the improvement of overexpression systems and the construction of two new libraries of C. albicans strains overexpressing genes for components of signaling networks, in particular protein kinases, protein phosphatases and transcription factors. As a proof of concept, we screened these collections for genes whose overexpression impacts morphogenesis or growth rates in C. albicans. Our screens identified genes previously described for their role in these biological processes, demonstrating the functionality of our strategy, as well as genes that have not been previously associated to these processes. This article emphasizes the potential of systematic overexpression strategies to improve our knowledge of regulatory networks in C. albicans. The C. albicans plasmid and strain collections described here are available at the Fungal Genetics Stock Center. Their extension to a genome-wide scale will represent important resources for the C. albicans community.

12 February 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SRSameh Rabhi
Sameh Rabhi
IRImen RABHI
Imen RABHI
BTBernadette Trentin
Bernadette Trentin
DPDavid Piquemal
David Piquemal
BRBeatrice Regnault
Beatrice Regnault
LGLamia Guizani-Tabbane
Lamia Guizani-Tabbane
Leishmania, the causative agent of vector-borne diseases, known as leishmaniases, is an obligate intracellular parasite within mammalian hosts. The outcome of infection depends largely on the activation status of macrophages, the first line of mammalian defense and the major target cells for parasite replication. Understanding the strategies developed by the parasite to circumvent macrophage defense mechanisms and to survive within those cells help defining novel therapeutic approaches for leishmaniasis. We previously showed the formation of lipid droplets (LDs) in L. major infected macrophages. Here, we provide novel insights on the origin of the formed LDs by determining their cellular distribution and to what extent these high-energy sources are directed to the proximity of Leishmania parasites. We show that the ability of L. major to trigger macrophage LD accumulation is independent of parasite viability and uptake and can also be observed in non-infected cells through paracrine stimuli suggesting that LD formation is from cellular origin. The accumulation of LDs is demonstrated using confocal microscopy and live-cell imagin in parasite-free cytoplasmic region of the host cell, but also promptly recruited to the proximity of Leishmania parasites. Indeed LDs are observed inside parasitophorous vacuole and in parasite cytoplasm suggesting that Leishmania parasites besides producing their own LDs, may take advantage of these high energy sources. Otherwise, these LDs may help cells defending against parasitic infection. These metabolic changes, rising as common features during the last years, occur in host cells infected by a large number of pathogens and seem to play an important role in pathogenesis. Understanding how Leishmania parasites and different pathogens exploit this LD accumulation will help us define the common mechanism used by these different pathogens to manipulate and/or take advantage of this high-energy source.